[Skip to Content]
[Skip to Content Landing]
November 21, 2001

Guidelines for Diagnosis and Treatment of High Cholesterol

Author Affiliations

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(19):2400-2402. doi:10.1001/jama.286.19.2398

To The Editor: The NCEP-ATP III Executive Summary1 states that "diabetes counts as a CHD risk equivalent because it confers a high risk of new CHD within 10 years."

This conclusion may be based in large part upon the study by Haffner et al2 of myocardial infarction risk in subjects with type 2 diabetes mellitus without previous myocardial infarction. The cardiovascular risk of diabetes is likely related to the degree of control, however. It may only be appropriate to consider poorly controlled diabetes to be a CHD risk equivalent, as the subjects in the report by Haffner et al had a fasting plasma glucose of 210 mg/dL (11.67 mmol/L).